Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.
Branden D TarlowW Ray KimAjitha MannalitharaPaul Yien KwoC Andrew BonhamAllison J KwongPublished in: Hepatology (Baltimore, Md.) (2022)
MELD 3.0 scores beyond 40 are associated with increasing waitlist mortality without adversely affecting posttransplant outcome. Uncapping the MELD score in waitlist candidates may lead to greater survival benefit from LT.